PART I: Drug Discovery and Development
1. Historical Perspective and Overview of Drug Discovery
2. Drug discovery: Hit and Lead Discovery
3. Drug Discovery: Optimization of Lead Properties
PART II: Classes of Drug Targets
4. Medicinal Chemistry Strategies Used in Lead Optimization
5. The Process of Developing a Drug from an Optimized Lead
6. Receptors as Drug Targets
7. Enzymes as Drug Targets
8. Protein-Protein Interactions and Lipids as Drug Targets
9. DNA and RNA as Drug Targets
PART III: Selected Therapeutic Areas
10. Anti-Cancer Drugs
11. Infectious Diseases I: Antiviral and Antifungal Drugs
12. Infectious Diseases II: Antibacterial and Antiparasitic Drugs
13. Drugs Acting on the CNS
Biography
Norma Dunlap is Professor of Chemistry at Middle Tennessee State University, where she specializes in synthetic organic chemistry and medicinal chemistry. Her research interests include the design and synthesis of bioactive compounds, as well as isolation, identification, and synthesis of bioactive natural products. She holds a PhD in Organic Chemistry from the University of Wyoming and was an NIH Postdoctoral Fellow at the University of Pennsylvania. Prior to an academic career, she was a Senior Research Scientist in drug discovery at Hoffmann-LaRoche.Donna M. Huryn is Research Professor in the Department of Pharmaceutical Sciences at the University of Pittsburgh and Adjunct Professor of Chemistry at the University of Pennsylvania and. Her research focuses on identi_cation, characterization, and optimization of small molecule probes and drugs to treat cancer, neurodegeneration and infectious diseases. She holds a PhD from the University of Pennsylvania and started her career as a medicinal chemist in the pharmaceutical industry. She is the Principal Investigator of the University of Pittsburgh Chemical Diversity Center and is a Fellow of the American Chemical Society.
